首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药调血脂的研究进展
引用本文:佘一鸣,胡永慧,张莉野,刘素香,陈常青.中药调血脂的研究进展[J].中草药,2017,48(17):3636-3644.
作者姓名:佘一鸣  胡永慧  张莉野  刘素香  陈常青
作者单位:天津中医药大学, 天津 300193;天津药物研究院, 天津 300193;哈尔滨商业大学药学院, 黑龙江 哈尔滨 150076;天津药物研究院, 天津 300193;哈尔滨商业大学药学院, 黑龙江 哈尔滨 150076;天津药物研究院, 天津 300193;天津药物研究院, 天津 300193;天津药物研究院, 天津 300193
摘    要:高脂血症是临床常见疾病,发病率逐年增高,发病人群也逐渐增大。高脂血症容易导致动脉粥样硬化、冠心病等心脑血管疾病,危害人类健康。临床上,化学药针对高脂血症有很好的疗效,但存在毒副作用甚至毒性,长时间服用也存在耐药性等问题。中药在中医药理论的指导下,具有疗效好且毒副作用小的特点,在临床上能够辨证治疗,发挥中医药特色,具有明显的优势。对中药单体成分、单味中药、中药复方和中西医结合治疗高脂血症进行综述,并分析探讨调血脂中药的开发前景及存在的问题。

关 键 词:高脂血症  中药  中药单体  中药复方  中西医结合  调血脂作用
收稿时间:2017/6/11 0:00:00

Research progress on blood lipid regulating effects of Chinese materia medica
SHE Yi-ming,HU Yong-hui,ZHANG Li-ye,LIU Su-xiang and CHEN Chang-qing.Research progress on blood lipid regulating effects of Chinese materia medica[J].Chinese Traditional and Herbal Drugs,2017,48(17):3636-3644.
Authors:SHE Yi-ming  HU Yong-hui  ZHANG Li-ye  LIU Su-xiang and CHEN Chang-qing
Institution:Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China;School of Pharmacy, Harbin University of Commerce, Harbin 150076, China;Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China;School of Pharmacy, Harbin University of Commerce, Harbin 150076, China;Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China;Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China;Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China
Abstract:Hyperlipidemia is a common clinical disease. In recent years, the incidence of hyperlipidemia increased, and patients gradually increased. Hyperlipidemia easily leads to atherosclerosis, coronary heart disease and other cardiovascular and cerebrovascular diseases, and causes crisis to human health. Clinically, Western medicine treatment has a good effect, but also the existence of side effects and even toxic effects, long-term use of drug resistance and other issues. Chinese materia medica (CMM) under the guidance of traditional Chinese medicine theory, with good efficacy and side effects of small features in the clinical dialectical treatment, plays the characteristics of Chinese medicine, and has obvious advantages. In this paper, CMM monomer, single CMM, compound, and integrated traditional Chinese and Western medicine in the treatment of hyperlipidemia were reviewed, and Chinese medicine lipid-lowering development prospects and problems were analyzed.
Keywords:hyperlipidemia  Chinese materia medica  Chinese materia medica monomer  Chinese materia medica compound  integrated traditional Chinese and western medicine  blood lipid regulating effects
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号